I

IQVIA Holdings

IQV

248.190
USD
1.947
(0.79%)
Market Closed
Volume
32,197
EPS
0
Div Yield
0
P/E
30
Market Cap
41,619,090,000
Related Instruments
A
1.430
(1.01%)
142.860 USD
ABT
4.220
(3.98%)
110.150 USD
BDX
-4.995
(-2.07%)
236.055 USD
D
DGX
5.430
(3.81%)
147.770 USD
GILD
0.470
(0.62%)
76.510 USD
I
ILMN
-0.250
(-0.20%)
122.370 USD
L
LH
18.230
(8.46%)
233.670 USD
MRK
0.680
(0.60%)
113.800 USD
PFE
0.115
(0.38%)
30.650 USD
TMO
9.03
(1.47%)
621.78 USD
News

Title: IQVIA Holdings

Sector: Healthcare
Industry: Diagnostics & Research
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.